VOLITIONRX LTD — Director's Dealing 2014

Oct 3, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-06-01

Reporting Person: Skaff Habib (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6286	Direct
Common Stock	2000	Direct
Common Stock	3112	Direct
Common Stock	3182	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$2.6	2016-05-10	Common Stock (3143)		Direct
Option	$3	2015-05-25	Common Stock (4000)		Direct
Option	$3	2015-11-25	Common Stock (4000)		Direct
Option	$4	2016-05-25	Common Stock (4000)		Direct
Option	$4	2016-11-25	Common Stock (4000)		Direct
Option	$5	2017-05-25	Common Stock (4000)		Direct
Option	$5	2017-11-25	Common Stock (4000)		Direct
Option	$2.5	2019-02-18	Common Stock (12500)		Direct
Option	$3	2020-02-18	Common Stock (12500)		Direct

Footnotes

F1: A total of 6,286 Units (1 Unit = 1 common share + 1 warrant to purchase 1/2 a common share) were acquired on May 11, 2012 at a cost basis of $1.75 per Unit, as settlement for certain debts owed to Dr. Habib Skaff by the Company. The warrant is at $2.60 for 4 years.

F2: On March 25, 2013, Mr. Skaff received 2,000 shares of the Company's common stock with a cost basis of $2.20 per share, as settlement for certain debts owed to Mr. Skaff by the Company.

F3: On August 16, 2013, Dr. Skaff received 3,112 shares of the Company's common stock with a cost basis of $2.25 per share, as settlement for certain debts owed to Dr. Skaff by the Company.

F4: On September 24, 2013, Dr. Skaff received 3,182 shares of the Company's common stock with a cost basis of $2.20 per share, as settlement for certain debts owed to Dr. Skaff by the Company.

F5: A total of 24,000 Options were issued on November 25, 2011 under the Company's 2011 Equity Inventive Plan.

F6: A total of 25,000 Options were issued on August 18, 2014 under the Company's 2011 Equity Inventive Plan.